IAPP inhibitor (WaveBreak Therapeutics)

N/A

Report date: 2025/03/20 15:29:41

Base Information

Drug NameIAPP inhibitor (WaveBreak Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIslet amyloid polypeptide inhibitors
TargetsIslet amyloid polypeptide
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWaveBreak Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWaveBreak Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A